BioMarin Pharmaceutical, Inc.
(NASDAQ : BMRN)

( )
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Interested in Gold Updates?
Receive the latest updates on the gold and silver markets.
100% secure: your email is never shared, and you may opt out at any time.
...
Health Technology » Biotechnology
symbolcompany%chnglast%shortavg$volume
AMGNAmgen Inc.
1.19%171.711.3%$501.07m
BIIBBiogen Inc.
1.43%236.251.3%$486.12m
CELGCelgene Corporation
0.19%96.431.3%$469.50m
GILDGilead Sciences, Inc.
0.00%66.520.9%$452.15m
ILMNIllumina, Inc.
2.21%313.253.5%$316.64m
REGNRegeneron Pharmaceuticals, Inc.
3.24%319.982.6%$293.71m
AAgilent Technologies, Inc.
-0.19%68.191.6%$199.57m
VRTXVertex Pharmaceuticals Incorporated
2.86%173.951.9%$182.65m
EXASExact Sciences Corporation
-1.50%95.5025.3%$168.27m
ALXNAlexion Pharmaceuticals, Inc.
-0.37%128.332.0%$150.89m
BMRNBioMarin Pharmaceutical Inc.
0.60%88.004.3%$118.41m
SRPTSarepta Therapeutics, Inc.
0.78%122.1414.7%$116.38m
INCYIncyte Corporation
0.93%79.412.5%$107.73m
IONSIonis Pharmaceuticals, Inc.
-0.88%68.638.2%$98.48m
ALNYAlnylam Pharmaceuticals, Inc
1.08%68.609.2%$96.64m

Company Profile

BioMarin Pharmaceutical, Inc. is a biotechnology company, which develops and commercializes therapies for people with serious and life-threatening rare diseases and medical conditions. Its products include Aldurazyme, Brineura, Kuvan, Naglazyme, Palynziq and Vimizim. The company was founded by Christopher M. Starr and Grant W. Denison on March 21, 1997 and is headquartered in San Rafael, CA.